Citius Oncology, Inc. CTOR Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s common stock, shares, outstanding?
- Citius Oncology, Inc. (CTOR) reported common stock, shares, outstanding of $92.98M in Q1 2026.
- How has Citius Oncology, Inc.'s common stock, shares, outstanding changed year-over-year?
- Citius Oncology, Inc.'s common stock, shares, outstanding increased by 29.9% year-over-year, from $71.55M to $92.98M.
- What is the long-term trend for Citius Oncology, Inc.'s common stock, shares, outstanding?
- Over 3 years (2022 to 2025), Citius Oncology, Inc.'s common stock, shares, outstanding has grown at a 264.5% compound annual growth rate (CAGR), from $1.73M to $83.51M.